BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34152391)

  • 1. 14-3-3 and erlin proteins differentially interact with RIPK2 complexes.
    Steinle H; Ellwanger K; Mirza N; Briese S; Kienes I; Pfannstiel J; Kufer TA
    J Cell Sci; 2021 Jun; 134(12):. PubMed ID: 34152391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.
    Heim VJ; Dagley LF; Stafford CA; Hansen FM; Clayer E; Bankovacki A; Webb AI; Lucet IS; Silke J; Nachbur U
    EMBO Rep; 2020 Nov; 21(11):e50400. PubMed ID: 32954645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription of NOD1 and NOD2 and their interaction with CARD9 and RIPK2 in IFN signaling in a perciform fish, the Chinese perch,
    Peng XY; Wang KL; Li L; Li B; Wu XY; Zhang ZW; Li N; Liu LH; Nie P; Chen SN
    Front Immunol; 2024; 15():1374368. PubMed ID: 38715616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assaying RIPK2 Activation by Complex Formation.
    Steinle H; Ellwanger K; Kufer TA
    Methods Mol Biol; 2022; 2523():133-150. PubMed ID: 35759195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
    Hrdinka M; Schlicher L; Dai B; Pinkas DM; Bufton JC; Picaud S; Ward JA; Rogers C; Suebsuwong C; Nikhar S; Cuny GD; Huber KV; Filippakopoulos P; Bullock AN; Degterev A; Gyrd-Hansen M
    EMBO J; 2018 Sep; 37(17):. PubMed ID: 30026309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures.
    Ellwanger K; Briese S; Arnold C; Kienes I; Heim V; Nachbur U; Kufer TA
    Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31350258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.
    Cavallari JF; Barra NG; Foley KP; Lee A; Duggan BM; Henriksbo BD; Anhê FF; Ashkar AA; Schertzer JD
    Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E579-E585. PubMed ID: 32101030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XIAP mediates NOD signaling via interaction with RIP2.
    Krieg A; Correa RG; Garrison JB; Le Negrate G; Welsh K; Huang Z; Knoefel WT; Reed JC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14524-9. PubMed ID: 19667203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIPK2 NODs to XIAP and IBD.
    Topal Y; Gyrd-Hansen M
    Semin Cell Dev Biol; 2021 Jan; 109():144-150. PubMed ID: 32631784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin regulates caspase recruitment domain-mediated signaling by nucleotide-binding oligomerization domain-containing proteins NOD1 and NOD2.
    Ver Heul AM; Fowler CA; Ramaswamy S; Piper RC
    J Biol Chem; 2013 Mar; 288(10):6890-902. PubMed ID: 23300079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target.
    Rivoal M; Dubuquoy L; Millet R; Leleu-Chavain N
    J Med Chem; 2023 Nov; 66(21):14391-14410. PubMed ID: 37857324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
    Canning P; Ruan Q; Schwerd T; Hrdinka M; Maki JL; Saleh D; Suebsuwong C; Ray S; Brennan PE; Cuny GD; Uhlig HH; Gyrd-Hansen M; Degterev A; Bullock AN
    Chem Biol; 2015 Sep; 22(9):1174-84. PubMed ID: 26320862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.
    Fan YH; Roy S; Mukhopadhyay R; Kapoor A; Duggal P; Wojcik GL; Pass RF; Arav-Boger R
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7818-E7827. PubMed ID: 27856764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
    Hasegawa M; Fujimoto Y; Lucas PC; Nakano H; Fukase K; Núñez G; Inohara N
    EMBO J; 2008 Jan; 27(2):373-83. PubMed ID: 18079694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional insights into CARDs of zebrafish (Danio rerio) NOD1 and NOD2, and their interaction with adaptor protein RIP2.
    Maharana J; Dehury B; Sahoo JR; Jena I; Bej A; Panda D; Sahoo BR; Patra MC; Pradhan SK
    Mol Biosyst; 2015 Aug; 11(8):2324-36. PubMed ID: 26079944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of nucleotide-binding oligomerization domain-containing protein 1 (NOD1) by receptor-interacting protein 2 (RIP2) is insufficient for signal transduction.
    Mayle S; Boyle JP; Sekine E; Zurek B; Kufer TA; Monie TP
    J Biol Chem; 2014 Aug; 289(33):22900-22914. PubMed ID: 24958724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.
    Shiny A; Regin B; Balachandar V; Gokulakrishnan K; Mohan V; Babu S; Balasubramanyam M
    Cytokine; 2013 Nov; 64(2):564-70. PubMed ID: 24018334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
    Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
    Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity.
    Damgaard RB; Nachbur U; Yabal M; Wong WW; Fiil BK; Kastirr M; Rieser E; Rickard JA; Bankovacki A; Peschel C; Ruland J; Bekker-Jensen S; Mailand N; Kaufmann T; Strasser A; Walczak H; Silke J; Jost PJ; Gyrd-Hansen M
    Mol Cell; 2012 Jun; 46(6):746-58. PubMed ID: 22607974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling.
    Damgaard RB; Fiil BK; Speckmann C; Yabal M; zur Stadt U; Bekker-Jensen S; Jost PJ; Ehl S; Mailand N; Gyrd-Hansen M
    EMBO Mol Med; 2013 Aug; 5(8):1278-95. PubMed ID: 23818254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.